Somerset Pharma - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsSomerset Pharma

Somerset Pharma

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Azelastine	Azelastine	2019-03-29	2023-2028	Allergic conjunctivitis , Allergic rhinitis perennial , Vasomotor rhinitis
Bimatoprost	Bimatoprost	2019-06-19	2023-2034	Heart failure , Hypertension , Myocardial infarction , Angina pectoris , Ocular hypertension , Open-angle glaucoma
Brimonidine	Brimonidine	2019-03-11	2024-2031	Skin diseases , Open-angle glaucoma , Ocular hypertension , Heart failure , Hypertension , Myocardial infarction , Angina pectoris
Cisatracurium besylate	Cisatracurium besylate	2019-02-20		—
Cyanocobalamin	Cyanocobalamin	2015-12-11	2024	Hypercholesterolemia, Hypophosphatemia, Hypertriglyceridemia, Peripheral vascular diseases, Dermatitis, Alcoholic neuropathy, Common cold, Seizures, Vitamin a deficiency, Hypoparathyroidism, Inborn errors metabolism, Photosensitivity disorders, Methemoglobinemia, Thiamine deficiency, Folic acid deficiency, Rickets, Vitamin b 6 deficiency, Megaloblastic anemia, Vitamin b deficiency, Xerophthalmia, Penetrating wounds, Tyrosinemias, Wernicke encephalopathy, Beriberi, Scurvy, Night blindness, Riboflavin deficiency, Pellagra, Chronic kidney failure, Cardiovascular diseases, Psoriasis, Lung neoplasms, Crohn disease, Skin neoplasms, Familial hypophosphatemic rickets, Osteoporosis
Dexamethasone	Dexamethasone	2018-04-19	2023-2039	Leukemia, Septic shock, Ulcerative colitis, Ankylosing spondylitis, Macular edema, Vomiting, Nausea, Uveitis, Sarcoidosis, Thrombocytopenic purpura idiopathic, Pulmonary tuberculosis, Mycosis fungoides, Systemic lupus erythematosus, Rheumatic diseases, Bursitis, Keratitis, Allergic rhinitis perennial, Thyroiditis, Iritis, Hypercalcemia, Brain edema, Pemphigus, Addison disease, Collagen diseases, Dermatitis herpetiformis, Wounds and injuries, Gastrointestinal diseases, Bacterial infections, Pseudomonas infections, Bacterial skin diseases, Skin diseases, Escherichia coli infections, Soft tissue infections, Bacterial eye infections, Urinary bladder diseases, Hepatic encephalopathy, Bacterial meningitis, Bacteremia, Klebsiella infections, Otitis externa, Haemophilus infections, Respiratory tract infections, Urinary tract infections, Intraabdominal infections, Infectious skin diseases, Staphylococcal infections, Central nervous system infections, Infectious bone diseases, Pain, Ventricular tachycardia, Cardiac arrhythmias, Burns, Esophageal diseases, Ventricular fibrillation, Ventricular premature complexes, Mouth diseases, Paroxysmal tachycardia, Neutropenia, Prostatitis, Fever, Sinusitis, Typhoid fever, Diarrhea, Gonorrhea, Osteomyelitis, Campylobacter infections, Bacterial conjunctivitis, Infectious arthritis, Pyelonephritis, Proteus infections, Anthrax, Protozoan infections, Cystitis, Dysentery, Bacteroides infections
Dorzolamide timolol	Dorzolamide, Timolol	2019-06-25		Heart failure, Hypertension, Myocardial infarction, Angina pectoris, Ocular hypertension, Open-angle glaucoma, Nephrotic syndrome, Edema
Eldepryl	Selegiline	1996-05-15		Parkinson disease, Alzheimer disease, Schizophrenia, Attention deficit disorder with hyperactivity, Depressive disorder
Emsam	Selegiline	2006-02-27		Parkinson disease, Alzheimer disease, Schizophrenia, Attention deficit disorder with hyperactivity, Depressive disorder
Epinastine	Epinastine	2011-10-31		Allergic conjunctivitis

1

2

3

4

5

>

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

cocaine-related disorders

,

healthy volunteers/patients

,

,

major depressive disorder

,

depressive disorder

,

tissue adhesions

© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use